{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T21:02:40Z","timestamp":1789419760200,"version":"build-2803163510"},"reference-count":25,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2013,3,8]],"date-time":"2013-03-08T00:00:00Z","timestamp":1362700800000},"content-version":"vor","delay-in-days":3476,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Clinical Pharma"],"published-print":{"date-parts":[[2003,9]]},"abstract":"<jats:p>Hydroxyurea has been shown to potentiate the activity of the antiretroviral nucleoside analogs. A significant complication of AIDS is invasion of the virus into the CNS, resulting in HIV\u2010associated dementia (HAD). Because of the polar nature of these nucleosides and the presence of efflux pumps in the blood\u2010brain barrier, only low CNS drug concentrations are achieved. Introduction of hydroxyurea into the CNS may therefore increase the antiviral activity of these drugs. This study evaluates the accessibility of hydroxyurea to the CNS following oral drug administration. Twelve HIV patients received 800 mg, 1000 mg, or 1200 mg oral hydroxyurea. Cerebrospinal fluid (CSF) and plasma drug concentrations were measured over 8 hours and simultaneously fitted to a pharmacokinetic model. It was determined that CSF hydroxyurea concentrations, corresponding to those found to increase antiretroviral nucleoside activity in vitro, were achieved.<\/jats:p>","DOI":"10.1177\/0091270003256144","type":"journal-article","created":{"date-parts":[[2003,9,10]],"date-time":"2003-09-10T01:25:00Z","timestamp":1063157100000},"page":"1003-1007","source":"Crossref","is-referenced-by-count":15,"title":["Pharmacokinetics of Hydroxyurea in Plasma and Cerebrospinal Fluid of HIV\u20101\u2010Infected Patients"],"prefix":"10.1002","volume":"43","author":[{"given":"Peter R.","family":"Gwilt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantine K.","family":"Manouilov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JoCarol","family":"McNabb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan S.","family":"Swindells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,3,8]]},"reference":[{"key":"e_1_2_5_2_2","first-page":"251","volume-title":"HIV, AIDS and the Brain","author":"McArthur JC","year":"1994"},{"key":"e_1_2_5_3_2","first-page":"131","article-title":"Response of human immunodeficiency virus\u2010associated neurological disease to 3'\u2010azido\u20103'\u2010deoxythymidine","volume":"8525","author":"Yarochoan R","year":"1987","journal-title":"Lancet"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198812153192404"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198810063191401"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.299.6703.819"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410330403"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199101173240301"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.3109\/13550289709031185"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1086\/515693"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.7973634"},{"key":"e_1_2_5_12_2","first-page":"160","article-title":"2', 3\u2010didehydro\u20103'\u2010deoxythymidine:regulation of its metabolic activation by modulators of thymidine\u20105'\u2010triphosphate biosynthesis","volume":"50","author":"Ahluwalia GS","year":"1996","journal-title":"Mol Pharmacol"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.18.8333"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0773.1990.tb00815.x"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001813-199410000-00009"},{"key":"e_1_2_5_16_2","first-page":"57","article-title":"Hydroxyurea (NSC\u201032065) in biologic fluids: dose\u2010concentration relationship","volume":"48","author":"Beckloff GL","year":"1965","journal-title":"Cancer Chemother Rep"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200107270-00007"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-4347(97)00634-8"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1998.00780.x"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1177\/00912700122012689"},{"key":"e_1_2_5_21_2","volume-title":"NONMEM 77","author":"NONMEM Project Group","year":"1992"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002800050256"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199834050-00002"},{"key":"e_1_2_5_24_2","first-page":"767","article-title":"Anti\u2010human immunodeficiency virus type 1 activity of hydroxyurea in combination with 2,3'\u2010dideoxynucleosides","volume":"46","author":"Gao W\u2010Y","year":"1994","journal-title":"Mol Pharmacol"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.18.8333"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(79)90546-8"}],"container-title":["The Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1177%2F0091270003256144","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/pdf\/10.1177\/0091270003256144","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T12:59:38Z","timestamp":1697461178000},"score":1,"resource":{"primary":{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/10.1177\/0091270003256144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,9]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2003,9]]}},"alternative-id":["10.1177\/0091270003256144"],"URL":"https:\/\/doi.org\/10.1177\/0091270003256144","archive":["Portico"],"relation":{},"ISSN":["0091-2700","1552-4604"],"issn-type":[{"value":"0091-2700","type":"print"},{"value":"1552-4604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,9]]}}}